Trisomy 12p syndrome

Trisomy 12p syndrome, also known as tetrasomy 12p (when involving an isochromosome) or partial trisomy 12p, is a rare chromosomal disorder caused by the presence of extra genetic material from the short arm (p) of chromosome 12. This condition is typically the result of an unbalanced chromosomal rearrangement, such as a translocation, leading to three copies of part or all of chromosome 12p. It should be distinguished from Pallister-Killian syndrome (tetrasomy 12p), which involves a supernumerary isochromosome 12p in mosaic form. Trisomy 12p syndrome affects multiple body systems and is characterized by a distinctive pattern of congenital anomalies. Key clinical features include intellectual disability of variable severity, craniofacial dysmorphism (such as a round flat face, full cheeks, short nose with a broad nasal bridge, long philtrum, thin upper lip, and low-set ears), muscular hypotonia, and short stature. Affected individuals may also present with congenital heart defects, skeletal anomalies, and feeding difficulties during infancy. Macrocephaly or relative macrocephaly has been reported in some cases. Developmental delay, particularly in speech and motor milestones, is a consistent finding. Seizures may occur in some patients. There is no specific cure for trisomy 12p syndrome. Management is supportive and symptomatic, tailored to the individual's clinical presentation. This may include early intervention programs, speech and physical therapy, cardiac evaluation and management of heart defects if present, and antiepileptic medications for seizures. Regular developmental assessments and multidisciplinary follow-up are recommended to optimize outcomes and quality of life.

Common questions about Trisomy 12p syndrome